SIGA Technologies (NASDAQ:SIGA) Stock Price Down 8.1%

Shares of SIGA Technologies, Inc. (NASDAQ:SIGA) dropped 8.1% during mid-day trading on Tuesday . The company traded as low as $9.37 and last traded at $9.59. Approximately 705,139 shares traded hands during trading, a decline of 26% from the average daily volume of 949,103 shares. The stock had previously closed at $10.44.

SIGA Technologies Price Performance

The stock’s fifty day simple moving average is $8.55 and its 200-day simple moving average is $7.75. The company has a market capitalization of $635.13 million, a P/E ratio of 8.87 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.03 earnings per share (EPS) for the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. The company had revenue of $21.81 million during the quarter. During the same quarter last year, the company earned ($0.04) earnings per share. On average, research analysts predict that SIGA Technologies, Inc. will post 1.01 earnings per share for the current year.

Institutional Investors Weigh In On SIGA Technologies

Hedge funds have recently made changes to their positions in the stock. DekaBank Deutsche Girozentrale bought a new position in SIGA Technologies during the second quarter worth about $40,000. Tower Research Capital LLC TRC increased its holdings in shares of SIGA Technologies by 200.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company’s stock worth $45,000 after buying an additional 5,309 shares in the last quarter. Steward Partners Investment Solutions LLC acquired a new stake in shares of SIGA Technologies during the fourth quarter worth approximately $58,000. Bayesian Capital Management LP acquired a new stake in shares of SIGA Technologies during the first quarter worth approximately $97,000. Finally, Lazard Asset Management LLC acquired a new stake in shares of SIGA Technologies during the first quarter worth approximately $105,000. Institutional investors own 55.40% of the company’s stock.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.